Natalizumab in patients with multiple sclerosis in Colombia: a case series
INTRODUCTION: Natalizumab is a humanized monoclonal antibody prescribed in the treatment of multiple sclerosis, the most prevalent chronic and inflammatory disease of the central nervous system (CNS). NEDA (no evidence of disease activity) status is the goal of multiple sclerosis treatment. METHO...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Asociación Colombiana de Neurología
2020-06-01
|
| Series: | Acta Neurológica Colombiana |
| Subjects: | |
| Online Access: | https://actaneurologica.com/index.php/anc/article/view/993 |